New and emerging drug therapies for the management of acute heart failure
- PMID: 14656255
- DOI: 10.1046/j.1445-5994.2003.00483.x
New and emerging drug therapies for the management of acute heart failure
Abstract
In recent times, there have been many developments in therapies for acute heart failure, in contrast to the preceding 20 years. These have been mainly fueled by new and expanding knowledge about the pathophysiology of heart failure, which has allowed for insight into potential therapeutic strategies. This review will examine the key emerging therapies for acute heart failure, in light of available pathophysiological and clinical evidence.
Similar articles
-
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.Am Heart J. 2003 Feb;145(2 Suppl):S26-33. doi: 10.1067/mhj.2003.151. Am Heart J. 2003. PMID: 12594449 Review. No abstract available.
-
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.Emerg Med Australas. 2004 Feb;16(1):47-54. doi: 10.1111/j.1742-6723.2004.00534.x. Emerg Med Australas. 2004. PMID: 15239755 Review.
-
The development of new medical treatments for acute decompensated heart failure.Heart Fail Monit. 2002;2(4):129-37. Heart Fail Monit. 2002. PMID: 12634887 Review.
-
Pharmacologic therapy for acute heart failure.Cardiol Clin. 2007 Nov;25(4):539-51; vi. doi: 10.1016/j.ccl.2007.08.007. Cardiol Clin. 2007. PMID: 18063158 Review.
-
Optimizing outcomes in the patient with acute decompensated heart failure.Am Heart J. 2006 Mar;151(3):571-9. doi: 10.1016/j.ahj.2005.04.034. Am Heart J. 2006. PMID: 16504617 Review.
Cited by
-
The disconnect between phase II and phase III trials of drugs for heart failure.Nat Rev Cardiol. 2013 Feb;10(2):85-97. doi: 10.1038/nrcardio.2012.181. Epub 2013 Jan 8. Nat Rev Cardiol. 2013. PMID: 23296069 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical